Stocks Health care TMCI
NASDAQ · Health careTreace Medical Concepts, Inc. (TMCI)
Treace Medical Concepts, Inc. brought in $205.3M of revenue over the twelve months to June 30, 2026, down 4.0% from a year earlier. It posted a net loss of $59.5M. In fiscal 2025 capital spending exceeded operating cash flow by $29.5M. At June 30, 2026 it held $12.6M in cash against $56M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 7, 2026.
What Treace Medical Concepts, Inc. does
Treace Medical Concepts, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker TMCI.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $212.7M | -$59M | -$0.93 | -$29.5M |
| 2024 | $209.4M | -$55.7M | -$0.90 | -$48.8M |
| 2023 | $187.1M | -$49.5M | -$0.81 | -$46M |
| 2022 | $141.8M | -$42.8M | -$0.77 | -$45.5M |
| 2021 | $94.4M | -$20.6M | -$0.43 | -$19.9M |
| 2021 | $57.4M | -$3.7M | -$0.12 | -$5.6M |
Latest SEC filings
What Treace Medical Concepts, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 12, 2026Passive stake changed SCHEDULE 13G/A
- August 7, 2026Quarterly report 10-Q · period to June 30, 2026
- August 7, 2026
- July 30, 2026Passive stake changed SCHEDULE 13G/A
- May 20, 2026
- May 15, 2026Passive stake changed SCHEDULE 13G/A
- May 14, 2026Passive stake (5% or more) SCHEDULE 13G
- May 8, 2026
- May 8, 2026Quarterly report 10-Q · period to March 31, 2026
Questions about TMCI
What does Treace Medical Concepts, Inc. do?
Treace Medical Concepts, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker TMCI.
Is Treace Medical Concepts, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $59.5M on revenue of $205.3M.
How much revenue does Treace Medical Concepts, Inc. make?
Over the twelve months to June 30, 2026 Treace Medical Concepts, Inc. reported revenue of $205.3M. That is 4.0% less than a year earlier.
When did Treace Medical Concepts, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 7, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from August 24, 2026.
Similar companies
Follow TMCI
Get an email when Treace Medical Concepts, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow TMCI: get an email when it filesWhere the numbers come from
Financial figures are the values Treace Medical Concepts, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.